Targeting B-cells mitigates autoimmune diabetes in NOD mice: What is plan B?

Diabetes

Volumn 58, Issue 7, 2009, Pages 1479-1481

  Smith, Susan H ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR MONOCLONAL ANTIBODY; B CELL MATURATION ANTIGEN; BASILIXIMAB; CD20 MONOCLONAL ANTIBODY; CD4 ANTIGEN; CHIMERIC PROTEIN; IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR ALPHA; RECOMBINANT B CELL MATURATION ANTIGEN FC CHIMERIZED PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DESTRUCTION; CELL INTERACTION; DIABETES MELLITUS; DISEASE SEVERITY; IMMUNOMODULATION; LYMPHOCYTE DEPLETION; NONHUMAN; NONOBESE DIABETIC MOUSE; NOTE; PANCREAS ISLET CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; B-LYMPHOCYTES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; IMMUNOTHERAPY; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED NOD;

EID: 67650251671     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0497     Document Type: Note

References (20)

1. + T-cells control autoimmunity in the absence of B-cells. Diabetes 2009;58:1568-1577
2. Xiu Y, Wong CP, Hamaguchi Y, Wang Y, Pop S, Tisch RM, Tedder TF. B lymphocytes depletion by CD20 monoclonal antibody prevents diabetes in NOD mice despite isotype-specific differences in FcγR effector functions. J Immunol 2008;180:2863-2875
3. Zekavat G, Rostami SY, Badkerhanian A, Parsons RF, Koeberlein B, Yu M, Ward CD, Migone TS, Yu L, Eisenbarth GS, Cancro MP, Naji A, Noorchashm H. In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol 2008;181:8133-8144
4. Hu CY, Rodriguez-Pinto D, Du W, Ahuja A, Henegariu O, Wong FS, Shlomchik MJ, Wen L. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 2007;117:3857-3867
5. Fiorina P, Vergani A, Dada S, Jurewicz M, Wong M, Law K, Wu E, Tian Z, Abdi R, Guleria I, Rodig S, Dunussi-Joannopoulos K, Bluestone J, Sayegh MH. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes 2008;57:3013-3024
6. null mice. J Exp Med 1996;184:2049-2053
7. Akashi T, Nagafuchi S, Anzai K, Kondo S, Kitamura D, Wakana S, Ono J, Kikuchi M, Niho Y, Watanabe T. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol 1997;9:1159-1164
8. Yang M, Charlton B, Gautam AM. Development of insulitis and diabetes in B cell-deficient NOD mice. J Autoimmun 1997;10:257-260
9. Chiu PP, Serreze DV, Danska JS. Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice. Diabetes 2001;50:763-770
10. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997;46:941-946
11. Lehuen A, Bendelac A, Bach JF, Carnaud C. The nonobese diabetic mouse model. Independent expression of humoral and cell-mediated autoimmune features. J Immunol 1990;144:2147-2151
12. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998;161:3912-3918
13. Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 1998;161:1163-1168
14. g7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice. J Immunol 1999;163:743-750
15. Wong FS, Wen L, Tang M, Ramanathan M, Visintin I, Daugherty J, Hannum LG, Janeway CA Jr, Shlomchik MJ. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 2004;53:2581-2587
16. + T cell activation in mice. Proc Natl Acad Sci U S A 2007;104:20882-20887
17. Quinn WJ 3rd, Noorchashm N, Crowley JE, Reed AJ, Noorchashm H, Naji A, Cancro MP. Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J Immunol 2006;176:7159-7164
18. Noorchashm H, Moore DJ, Noto LE, Noorchashm N, Reed AJ, Reed AL, Song HK, Mozaffari R, Jevnikar AM, Barker CF, Naji A. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol 2000;165:4685-4696
19. Yazawa N, Hamaguchi Y, Poe JC, Tedder TF. Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease. Proc Natl Acad Sci U S A 2005;102:15178-15183
20. Bouaziz J-D, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008;224:201-214